Currently out of the existing stock ratings of Daniel Markowitz, 40 are a BUY (78.43%), 11 are a HOLD (21.57%).

Daniel Markowitz

Work Performance Price Targets & Ratings Chart

Analyst Daniel Markowitz, currently employed at EVERCORE, carries an average stock price target met ratio of 66.64% that have a potential upside of 17.39% achieved within 87 days.

Daniel Markowitz’s has documented 103 price targets and ratings displayed on 9 stocks. The coverage is on Healthcare, Technology sectors.

Most recent stock forecast was given on NTRA, Natera at 07-Aug-2026.

Wall Street Analyst Daniel Markowitz

Analyst best performing recommendations are on GH (GUARDANT HEALTH).
The best stock recommendation documented was for GH (GUARDANT HEALTH) at 1/5/2026. The price target of $105 was fulfilled within 1 day with a profit of $3.13 (3.07%) receiving and performance score of 30.73.

Average potential price target upside

GH Guardant Health INSP Inspire Medical Systems NTRA Natera PODD Insulet RGEN Repligen RMBS Rambus TECH Bio-Techne Corp TMDX TransMedics Group WST West Pharmaceutical Services

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 15-Feb-2021

$200

$30.92 (18.29%)

$37

Buy Since 22-Jan-2025

$220

$50.92 (30.12%)

$200

17 days ago
(06-Oct-2026)

9/11 (81.82%)

$51.67 (30.70%)

90

Buy Since 21-Jan-2025

$200

$30.92 (18.29%)

$190

23 days ago
(30-Sep-2026)

6/8 (75%)

$25.25 (14.45%)

65

Buy Since 15-Apr-2019

$195

$25.92 (15.33%)

$195

1 months 22 days ago
(01-Sep-2026)

23/26 (88.46%)

$31.94 (19.59%)

377

Buy Since 27-Feb-2023

$185

$7.2 (4.05%)

$175

2 months 20 days ago
(04-Aug-2026)

7/8 (87.5%)

$25.21 (15.78%)

489

Show more analysts

Please expand the browser size to see the chart

Which stock is Daniel Markowitz most bullish on?

Potential upside of $74.35 has been obtained for RMBS (RAMBUS)

Which stock is Daniel Markowitz most reserved on?

Potential downside of -$74.08 has been obtained for GH (GUARDANT HEALTH)

What Year was the first public recommendation made by Daniel Markowitz?

On 2025
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?